Wang Xinfeng, Cheang Wai San, Yang Haixia, Xiao Lei, Lai Baochang, Zhang Meiqian, Ni Jiahua, Luo Zhenyu, Zhang Zihui, Huang Yu, Wang Nanping
Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an, China.
Department of Physiology and Pathophysiology, School of Medicine, Xi'an Jiaotong University, Xi'an, China.
Br J Pharmacol. 2015 Dec;172(23):5609-18. doi: 10.1111/bph.13021. Epub 2015 Jan 23.
Nuciferine, a constituent of lotus leaf, is an aromatic ring-containing alkaloid, with antioxidative properties. We hypothesize nuciferine might affect vascular reactivity. This study aimed at determining the effects of nuciferine on vasomotor tone and the underlying mechanism
Nuciferine-induced relaxations in rings of rat main mesenteric arteries were measured by wire myographs. Endothelial NOS (eNOS) was determined by immunoblotting. Intracellular NO production in HUVECs and Ca(2+) level in both HUVECs and vascular smooth muscle cells (VSMCs) from rat mesenteric arteries were assessed by fluorescence imaging.
Nuciferine induced relaxations in arterial segments pre-contracted by KCl or phenylephrine. Nuciferine-elicited arterial relaxations were reduced by removal of endothelium or by pretreatment with the eNOS inhibitor L-NAME or the NO-sensitive guanylyl cyclase inhibitor ODQ. In HUVECs, the phosphorylation of eNOS at Ser(1177) and increase in cytosolic NO level induced by nuciferine were mediated by extracellular Ca(2+) influx. Under endothelium-free conditions, nuciferine attenuated CaCl2-induced contraction in Ca(2+)-free depolarizing medium. In the absence of extracellular calcium, nuciferine relieved the vasoconstriction induced by phenylephrine and the addition of CaCl2. Nuciferine also suppressed Ca(2+) influx in Ca(2+)-free K(+)-containing solution in VSMCs.
Nuciferine has a vasorelaxant effect via both endothelium-dependent and -independent mechanisms. These results suggest that nuciferine may have a therapeutic effect on vascular diseases associated with aberrant vasoconstriction.
荷叶中的成分荷叶碱是一种含芳香环的生物碱,具有抗氧化特性。我们推测荷叶碱可能会影响血管反应性。本研究旨在确定荷叶碱对血管舒缩张力的影响及其潜在机制。
用线式肌张力测定仪测量荷叶碱诱导的大鼠肠系膜主动脉环舒张情况。通过免疫印迹法测定内皮型一氧化氮合酶(eNOS)。采用荧光成像评估人脐静脉内皮细胞(HUVECs)内的一氧化氮生成以及大鼠肠系膜动脉的HUVECs和血管平滑肌细胞(VSMCs)中的钙离子水平。
荷叶碱可诱导由氯化钾或去氧肾上腺素预收缩的动脉段舒张。去除内皮或用eNOS抑制剂L - 精氨酸甲酯(L - NAME)或一氧化氮敏感的鸟苷酸环化酶抑制剂1H - [1,2,4]恶二唑并[4,3 - a]喹喔啉 - 1 - 酮(ODQ)预处理后,荷叶碱引起的动脉舒张作用减弱。在HUVECs中,荷叶碱诱导的eNOS第1177位丝氨酸(Ser(1177))磷酸化及胞质一氧化氮水平升高是由细胞外钙离子内流介导的。在无内皮条件下,荷叶碱可减弱氯化钙在无钙去极化培养基中诱导的收缩。在无细胞外钙的情况下,荷叶碱可缓解去氧肾上腺素诱导的血管收缩以及氯化钙的加入。荷叶碱还可抑制VSMCs在无钙含钾溶液中的钙离子内流。
荷叶碱通过内皮依赖和非依赖机制产生血管舒张作用。这些结果表明荷叶碱可能对与血管异常收缩相关的血管疾病具有治疗作用。